Drug-review deadlines linked to safety problems

Author：

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1196, 2008-01, pp. : 1-1

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

By Krähenbühl-Melcher Anita

Drug Safety, Vol. 30, Iss. 5, 2007-01 ,pp. : 379-407

Adis International

Access to resources Recommend Favorite

Case Series in Drug Safety: A Review to Determine Characteristics and Quality

By >

Drug Safety, Vol. 33, Iss. 12, 2010-12 ,pp. : 1081-1088

Adis International

Access to resources Recommend Favorite

Safety Considerations in Drug Treatment of Depression in HIV-Positive Patients: An Updated Review

By Watkins Crystal C.

Drug Safety, Vol. 34, Iss. 8, 2011-08 ,pp. : 623-639

Adis International

Access to resources Recommend Favorite

Initiating antiretrovirals during tuberculosis treatment: a drug safety review

By Gengiah Tanuja N Gray Andrew L Naidoo Kogieleum Karim Quarraisha Abdool

Expert Opinion on Drug Safety, Vol. 10, Iss. 4, 2011-07 ,pp. : 559-574

Informa Healthcare

Access to resources Recommend Favorite

Impact of Regulatory Guidances and Drug Regulation on Risk Minimization Interventions in Drug Safety: A Systematic Review

By Nkeng Lenhangmbong Cloutier Anne-Marie Craig Camille Lelorier Jacques Moride Yola

Drug Safety, Vol. 35, Iss. 7, 2012-07 ,pp. : 535-546

Adis International

Access to resources Recommend Favorite